Alistair Macdonald Sells 2,348 Shares of INC Research Holdings, Inc. (INCR) Stock

INC Research Holdings, Inc. (NASDAQ:INCR) CEO Alistair Macdonald sold 2,348 shares of the stock in a transaction on Monday, September 18th. The stock was sold at an average price of $54.60, for a total value of $128,200.80. Following the sale, the chief executive officer now directly owns 99,453 shares in the company, valued at $5,430,133.80. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

Alistair Macdonald also recently made the following trade(s):

  • On Thursday, August 17th, Alistair Macdonald sold 8,828 shares of INC Research Holdings stock. The stock was sold at an average price of $55.65, for a total value of $491,278.20.
  • On Monday, July 3rd, Alistair Macdonald sold 10,555 shares of INC Research Holdings stock. The stock was sold at an average price of $58.38, for a total value of $616,200.90.

INC Research Holdings, Inc. (INCR) traded down 1.37% during mid-day trading on Tuesday, hitting $53.80. The stock had a trading volume of 1,087,411 shares. The stock has a market capitalization of $2.91 billion, a P/E ratio of 32.97 and a beta of 1.41. The company’s 50 day moving average is $56.03 and its 200-day moving average is $52.60. INC Research Holdings, Inc. has a 52 week low of $40.65 and a 52 week high of $61.10.

INC Research Holdings (NASDAQ:INCR) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.64 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.64. INC Research Holdings had a return on equity of 40.69% and a net margin of 5.69%. The company had revenue of $258.10 million for the quarter, compared to analyst estimates of $256.76 million. During the same period in the previous year, the company posted $0.61 EPS. The firm’s revenue for the quarter was down .3% compared to the same quarter last year. On average, analysts expect that INC Research Holdings, Inc. will post $2.62 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This report was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at https://www.chaffeybreeze.com/2017/09/19/alistair-macdonald-sells-2348-shares-of-inc-research-holdings-inc-incr-stock.html.

Several large investors have recently added to or reduced their stakes in the stock. Koch Industries Inc. bought a new stake in shares of INC Research Holdings during the 2nd quarter valued at $499,000. Ameritas Investment Partners Inc. grew its position in INC Research Holdings by 483.3% during the second quarter. Ameritas Investment Partners Inc. now owns 20,860 shares of the company’s stock worth $1,220,000 after buying an additional 17,284 shares in the last quarter. Castleark Management LLC purchased a new position in INC Research Holdings during the second quarter worth about $14,277,000. California State Teachers Retirement System grew its position in INC Research Holdings by 18.6% during the second quarter. California State Teachers Retirement System now owns 96,717 shares of the company’s stock worth $5,658,000 after buying an additional 15,179 shares in the last quarter. Finally, The Manufacturers Life Insurance Company grew its position in INC Research Holdings by 272.1% during the second quarter. The Manufacturers Life Insurance Company now owns 119,772 shares of the company’s stock worth $7,006,000 after buying an additional 87,583 shares in the last quarter. Institutional investors own 98.97% of the company’s stock.

Several research firms have recently issued reports on INCR. Goldman Sachs Group, Inc. (The) reissued a “buy” rating and set a $65.00 target price on shares of INC Research Holdings in a report on Monday, August 7th. William Blair lowered INC Research Holdings from an “outperform” rating to a “market perform” rating in a report on Tuesday, June 20th. SunTrust Banks, Inc. raised INC Research Holdings from a “hold” rating to a “buy” rating and increased their target price for the stock from $48.00 to $67.00 in a report on Wednesday, May 31st. Jefferies Group LLC lowered INC Research Holdings from a “buy” rating to a “hold” rating and increased their target price for the stock from $62.00 to $64.00 in a report on Thursday, June 29th. Finally, KeyCorp raised INC Research Holdings from a “sector weight” rating to an “overweight” rating and set a $68.00 target price on the stock in a report on Monday, June 5th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company. INC Research Holdings presently has an average rating of “Hold” and an average target price of $63.79.

INC Research Holdings Company Profile

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Insider Buying and Selling by Quarter for INC Research Holdings (NASDAQ:INCR)

Receive News & Ratings for INC Research Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply